Prognostic Value and Related Molecular Mechanisms of miR‐5003‐3p in Hepatocellular Carcinoma
Canadian Journal of Gastroenterology and Hepatology · 2026-01 · 2026 (1)
DOI: 10.1155/cjgh/1318790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, online erschienen am 05.04.2026. Verfasst von Hao Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Vascular Surgery, General Hospital of Northern Theater Command, Shenyang, 110001, China, syjqzyy.com. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is a malignant tumor worldwide with a high mortality rate and recurrence rate. Numerous miRNAs are being applied to the healing and prognosis of HCC. A prior investigation predicted that miR‐5003‐3p was linked to HCC, but the relevant molecular mechanisms were not clear.
Aim
To discover the prognostic value and molecular mechanisms concerned of miR‐5003‐3p in HCC.
Methods
A total of 125 tumor specimens from HCC patients were obtained in this study, along with corresponding adjacent noncancerous tissue samples collected as a control. The levels of miR‐500‐3p and MAL2 in tumor tissues and cells were detected by RT‐qPCR. The prognostic value of miR‐500‐3p was evaluated using Kaplan–Meier curve and COX regression model. The effects of miR‐500‐3p on cellular malignant phenotypes were assessed via CCK‐8 and Transwell assays. The target sites of miR‐500‐3p were identified using bioinformatics analysis. The dual‐luciferase reporter assay validated the target relationship between them. Results miR‐5003‐3p levels were remarkably elevated in HCC tissues, and late TNM stage (I + II) was dramatically higher versus early TNM stage (III + IV). Lymph node metastasis, TNM stage, and differentiated degree were linked notably to miR‐5003‐3p expression. Upregulated miR‐5003‐3p was an independent risk factor for HCC. In vitro, downregulated miR‐5003‐3p could induce apoptosis and restrain proliferation, migration, and invasion, which could be rescued by depressed MAL2. Conclusion miR‐5003‐3p may be an independent prognostic factor for HCC. Mechanistically, miR‐5003‐3p negatively regulates MAL2 to promote cellular processes. These findings highlight the potential of miR‐5003‐3p as a novel prognostic biomarker and a promising therapeutic target for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interventional Vascular Surgery, General Hospital of Northern Theater Command, Shenyang, 110001, China, syjqzyy.com.
- Department of Pathology, Beifang Hospital of China Medical University, General Hospital of Northern Theater Command, Shenyang, 110001, China, syjqzyy.com.
ORCID-Profile: Hao Yan, Wei Shan, Qian Xia, Wanting Fang
Zitieren
APA
Yan, H., Shan, W., Xia, Q., & Fang, W. (2026). Prognostic Value and Related Molecular Mechanisms of miR‐5003‐3p in Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology, 2026(1). https://doi.org/10.1155/cjgh/1318790
Vancouver
Yan H, Shan W, Xia Q, Fang W. Prognostic Value and Related Molecular Mechanisms of miR‐5003‐3p in Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology. 2026;2026(1). doi:10.1155/cjgh/1318790
BibTeX
@article{Yan2026,
author = {Yan, Hao and Shan, Wei and Xia, Qian and Fang, Wanting},
title = {Prognostic Value and Related Molecular Mechanisms of miR‐5003‐3p in Hepatocellular Carcinoma},
journal = {Canadian Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cjgh/1318790}
}
EUVIMED